Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients (FIKA)

Uppsala University

Status: Completed

Conditions: Colorectal Neoplasms

Treatments: Device: fecal occult blood test

Study type: Observational

Funder types: Other

Identifiers

NCT02491593

QFecalBlood 2013/2:7

Details and patient eligibility

About

The aim of this study is to compare the outcome of three (3) quantitative immunochemical faecal occult blood test in symptomatic patients.

Full description

Consecutive patients referred from primary care for colonoscopy due to symptoms are eligible. Patients will receive written information of the study together with the time for colonoscopy. A specific research nurse will call them and for those accepting participation, history and current medication will be collected. Kits will be sent to patients and they will provide three faecal samples before examination. These will be analysed at one certified laboratory.

Hemoglobin concentration will be notified in the range of 50 - < 1000 ng/mL, or as a negative outcome.

Macroscopic findings at the colonoscopy will be collected, as well as the outcome of the pathological report.

Enrollment: 242 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Symptoms associated with colorectal cancer (anemia, change of bowel habits, diarrhoea, constipation, haematochezia, weight loss, anorexia)

Exclusion criteria

• Screening investigations
• High-risk patients